ask="17.550"
ask_size="3800"
average_daily_volume="1402450"
bid="16.940"
bid_size="1000"
book_value="10.762"
change="+0.345"
change_from_200_day_moving_average="-1.739"
change_from_50_day_moving_average="0.996"
change_from_52_week_high="-22.365"
change_From_52_week_low="2.225"
change_in_percent="+2.026%"
close="17.375"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="0.885"
ebitda="143.80M"
eps_estimate_current_year="0.990"
eps_estimate_next_quarter="0.270"
eps_estimate_next_year="1.070"
ex_dividend_date="7/1/2009"
float_shares="60304000"
high="17.410"
high_52_weeks="39.740"
last_trade_date="2/15/2017"
last_trade_price="17.375"
last_trade_size="92828"
last_trade_time="4:00pm"
low="16.850"
low_52_weeks="15.150"
market_capitalization="1.18B"
moving_average_200_day="19.114"
moving_average_50_day="16.379"
name="Myriad Genetics
Inc."
notes="N/A"
one_year_target_price="19.090"
open="16.960"
pe_ratio="19.633"
peg_ratio="-5.620"
percent_change_from_200_day_moving_average="-9.099%"
percent_change_from_50_day_moving_average="+6.078%"
percent_change_from_52_week_high="-56.278%"
percent_change_from_52_week_low="+14.686%"
previous_close="17.030"
price_eps_estimate_current_year="17.551"
price_eps_Estimate_next_year="16.238"
price_per_book="1.582"
price_per_sales="1.544"
revenue="750.90M"
shares_outstanding="68091000"
short_ratio="21.260"
stock_exchange="NMS"
symbol="MYGN"
volume="1651517"
weeks_range_52="15.150 - 39.740"
